MedPath
FDA Approval

Fentanyl Citrate

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
December 18, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Fentanyl(50 ug in 1 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Exela Pharma Sciences, LLC

Exela Pharma Sciences, LLC

831274399

Products2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Fentanyl Citrate

Product Details

NDC Product Code
51754-2150
Application Number
NDA215870
Marketing Category
NDA (C73594)
Route of Administration
INTRAVENOUS
Effective Date
December 18, 2023
FentanylActive
Code: MUN5LYG46HClass: ACTIMQuantity: 50 ug in 1 mL
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT

Fentanyl Citrate

Product Details

NDC Product Code
51754-2160
Application Number
NDA215870
Marketing Category
NDA (C73594)
Route of Administration
INTRAVENOUS
Effective Date
December 18, 2023
FentanylActive
Code: MUN5LYG46HClass: ACTIMQuantity: 50 ug in 1 mL
WATERInactive
Code: 059QF0KO0RClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
© Copyright 2025. All Rights Reserved by MedPath